Oksana Koneva

ARKK is a major outperformer but share count falls each year, Michael Taylor notes

ARKK is a major outperformer but share count falls each year, Michael Taylor notes
ARKK outperformance and ETF share count

Michael Taylor, co-founder and portfolio manager at Agora Trading, observed that while ARKK has been a significant outperformer and has experienced fund flows, the ETF's share count has declined every year for multiple years. Taylor expressed uncertainty regarding this ongoing trend.

Taylor has recently commented on funding headwinds for TE related to its perceived Chinese ownership, raising concerns about the company's capital access here. He also noted AQRT's plans to launch a Phase 2 Vitiligo study in the fourth quarter of 2026, targeting a $1 billion market opportunity here. Taylor’s previous observations have focused on market access and growth prospects for individual firms.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.